Table 3.
The selected 50 clinical parameters in the prospective study.
| Clinical factors | ||
|---|---|---|
| Age, (years) | 71 | (60–79) |
| Gender, Male/Female | 135/78 | |
| NYHA class (II/III/IV) at admission | 47/108/58 | |
| Heart rate at admission (beats/min) | 80 | (68–97) |
| Leg edema | 136 | (64) |
| Cause of ADHF | ||
| Cardiomyopathy | 76 | (36) |
| Hypertensive heart disease | 29 | (14) |
| Ischemic heart disease | 26 | (12) |
| Valvular heart disease | 47 | (22) |
| Comorbidity | ||
| Hypertension | 108 | (51) |
| Hyperlipidemia | 73 | (34) |
| Chronic Af | 104 | (49) |
| Cerebrovascular disease | 14 | (7) |
| Obstructive pulmonary disease | 7 | (3) |
| CRT | 24 | (11) |
| ICD | 31 | (15) |
| Pacemaker | 25 | (12) |
| Number of family members in the same household | 1 | (1–2) |
| Albumin at admission, (g/dl) | 3.8 | (3.5–4.1) |
| CRP at admission, (mg/dl) | 0.4 | (0.1–1.1) |
| LVDs at admission, (mm) | 47 | (34–58) |
| %FS at admission, (%) | 18 | (10.3–30.6) |
| WBC at admission, (/μl) | 5240 | (4200–6400) |
| AST at discharge, (U/l) | 23 | (18–30) |
| BUN at discharge, (mg/dl) | 23 | (18–35) |
| Uric acid at discharge, (mg/dl) | 6.5 | (5.3–7.9) |
| CRP at discharge, (mg/dl) | 0.2 | (0.1–0.6) |
| BNP at discharge, (pg/ml) | 244.8 | (117–457) |
| %FS at discharge, (%) | 20.9 | (11–31.7) |
| IVST at discharge, (mm) | 10 | (8–11) |
| AR grade (≥II) at discharge | 26 | (12) |
| MR grade (≥II) at discharge | 93 | (44) |
| TR grade (≥II) at discharge | 59 | (28) |
| Oral medications at discharge | ||
| ACE inhibitor | 111 | (52) |
| Anti-allergic | 8 | (4) |
| Anti-inflammatory drug | 48 | (23) |
| Antiplatelet | 27 | (13) |
| Antithyroid drug | 3 | (1) |
| Beta-blockers | 161 | (76) |
| Bronchodilator | 2 | (1) |
| Cardiotonic drug | 36 | (17) |
| Choleretic drug | 11 | (5) |
| Digitalis | 42 | (20) |
| Diuretics | 181 | (85) |
| Intestinal disease drug | 19 | (9) |
| Lipid-lowering drug | 79 | (37) |
| Proton pump inhibitor | 119 | (56) |
| Purgative | 63 | (30) |
| Sedative-hypnotic (benzodiazepin) | 12 | (6) |
| Vitamins | 7 | (3) |
Data are given as the median (interquartile range) or n (%). ACE inhibitor, angiotensin-converting enzyme inhibitor; ADHF, acute decompensated heart failure; Af, atrial fibrillation; AR, aortic regurgitation; BNP, B-type natriuretic peptide; BUN, Blood urea nitrogen; CRT, cardiac resynchronization therapy; CRP, C-reactive protein; FS, fractional shortening; ICD, Implantable Cardioverter Defibrillator; VST, interventricular septum thickness; LVDs, Left ventricular end-systolic dimension MR, mitral regurgitation; NYHA, New York Heart Association; TR, tricuspid regurgitation.